Valuation (12%) |
Company | Industry |
---|---|---|
P/E Ratio (TTM) | -5.34 | N/A |
PEG Ratio (TTM) | -0.45 | N/A |
P/S Ratio (TTM) | 101.55 | N/A |
P/B Ratio (TTM) | 1.99 | N/A |
P/FCF Ratio (TTM) | -6.70 | N/A |
Price to 5YR AVG Earnings Ratio | -2.74 | N/A |
Price to 5YR AVG FCF Ratio | -13.32 | N/A |
Profitability (0%) |
Company | Industry |
---|---|---|
ROA (TTM) | -30.59% | N/A |
ROE (TTM) | -52.98% | N/A |
Net Profit Margin (TTM) | -2,021.54% | N/A |
ROIC 5YR AVG | -1,609.20% | N/A |
Growth (0%) |
4QTR AVG | 3YR AVG | 5YR AVG |
---|---|---|---|
EPS | -38.15% | -16.56% | -10.83% |
Revenue | -25.00% | N/A | N/A |
Net Income | -51.41% | -1,053.02% | -642.48% |
Cash Flow | -2.23% | -3,753.74% | -2,259.80% |
Health (58%) |
Company | Industry |
---|---|---|
Current Ratio (TTM) | 9.00 | N/A |
Quick Ratio (TTM) | 9.00 | N/A |
D/E Ratio (TTM) | 0.09 | N/A |
Interest Coverage (TTM) | -57.57 | N/A |
Piotroski F-Score | 1 | N/A |
Altman Z-Score | 3.53 | N/A |
LTL to 5YR AVG FCF | -0.38 | N/A |
Shares Outstanding Growth 5YR AVG | 938.61% | N/A |